CRCAM DU LANGUEDOC (CRLA.PA) Stock Fundamental Analysis

EPA:CRLA • FR0010461053

80.5 EUR
-1.5 (-1.83%)
Last: Mar 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall CRLA gets a fundamental rating of 2 out of 10. We evaluated CRLA against 106 industry peers in the Banks industry. Both the profitability and financial health of CRLA have multiple concerns. CRLA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CRLA had positive earnings in the past year.
  • In the past year CRLA has reported a negative cash flow from operations.
  • CRLA had positive earnings in each of the past 5 years.
  • In multiple years CRLA reported negative operating cash flow during the last 5 years.
CRLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCRLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.51%, CRLA is doing worse than 67.92% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 3.23%, CRLA is doing worse than 79.25% of the companies in the same industry.
Industry RankSector Rank
ROA 0.51%
ROE 3.23%
ROIC N/A
ROA(3y)0.53%
ROA(5y)0.53%
ROE(3y)3.75%
ROE(5y)3.8%
ROIC(3y)N/A
ROIC(5y)N/A
CRLA.PA Yearly ROA, ROE, ROICCRLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

1.3 Margins

  • CRLA's Profit Margin of 25.59% is fine compared to the rest of the industry. CRLA outperforms 60.38% of its industry peers.
  • CRLA's Profit Margin has declined in the last couple of years.
  • The Operating Margin and Gross Margin are not available for CRLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 25.59%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.9%
PM growth 5Y-3.43%
GM growth 3YN/A
GM growth 5YN/A
CRLA.PA Yearly Profit, Operating, Gross MarginsCRLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • CRLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CRLA remains at a similar level compared to 1 year ago.
  • CRLA has less shares outstanding than it did 5 years ago.
  • CRLA has a worse debt/assets ratio than last year.
CRLA.PA Yearly Shares OutstandingCRLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CRLA.PA Yearly Total Debt VS Total AssetsCRLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • A Debt/Equity ratio of 0.02 indicates that CRLA is not too dependend on debt financing.
  • CRLA has a better Debt to Equity ratio (0.02) than 91.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.33%
CRLA.PA Yearly LT Debt VS Equity VS FCFCRLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRLA.PA Yearly Current Assets VS Current LiabilitesCRLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • CRLA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.09%.
  • Measured over the past years, CRLA shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.36% on average per year.
  • The Revenue has decreased by -2.48% in the past year.
  • Measured over the past years, CRLA shows a small growth in Revenue. The Revenue has been growing by 2.09% on average per year.
EPS 1Y (TTM)1.09%
EPS 3Y-6.33%
EPS 5Y-1.36%
EPS Q2Q%9.28%
Revenue 1Y (TTM)-2.48%
Revenue growth 3Y0.57%
Revenue growth 5Y2.09%
Sales Q2Q%0.85%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRLA.PA Yearly Revenue VS EstimatesCRLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • CRLA is valuated reasonably with a Price/Earnings ratio of 8.65.
  • 83.02% of the companies in the same industry are more expensive than CRLA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CRLA to the average of the S&P500 Index (27.13), we can say CRLA is valued rather cheaply.
Industry RankSector Rank
PE 8.65
Fwd PE N/A
CRLA.PA Price Earnings VS Forward Price EarningsCRLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRLA.PA Per share dataCRLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1K 2K 3K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.26%, CRLA has a reasonable but not impressive dividend return.
  • CRLA's Dividend Yield is slightly below the industry average, which is at 4.33.
  • CRLA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.26%

5.2 History

  • The dividend of CRLA has a limited annual growth rate of 2.79%.
Dividend Growth(5Y)2.79%
Div Incr Years0
Div Non Decr Years0
CRLA.PA Yearly Dividends per shareCRLA.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
CRLA.PA Yearly Income VS Free CF VS DividendCRLA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

More info and screens

Find the best dividend stocksShow peers with best dividend

CRCAM DU LANGUEDOC

EPA:CRLA (3/2/2026, 7:00:00 PM)

80.5

-1.5 (-1.83%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-22
Earnings (Next)04-28
Inst Owners7.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap144.90M
Revenue(TTM)719.89M
Net Income(TTM)184.24M
Analysts78.18
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.26%
Yearly DividendN/A
Dividend Growth(5Y)2.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.65
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.03
EV/EBITDA N/A
EPS(TTM)9.31
EY11.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-182.04
FCFYN/A
OCF(TTM)-179.3
OCFYN/A
SpS399.94
BVpS3173.82
TBVpS3173.82
PEG (NY)N/A
PEG (5Y)N/A
Graham Number815.38
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 3.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.59%
GM N/A
FCFM N/A
ROA(3y)0.53%
ROA(5y)0.53%
ROE(3y)3.75%
ROE(5y)3.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.9%
PM growth 5Y-3.43%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC6.33%
ROIC/WACCN/A
Cap/Depr(3y)97.89%
Cap/Depr(5y)99.63%
Cap/Sales(3y)2.1%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.09%
EPS 3Y-6.33%
EPS 5Y-1.36%
EPS Q2Q%9.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.48%
Revenue growth 3Y0.57%
Revenue growth 5Y2.09%
Sales Q2Q%0.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.88%
OCF growth 3YN/A
OCF growth 5YN/A

CRCAM DU LANGUEDOC / CRLA.PA FAQ

Can you provide the ChartMill fundamental rating for CRCAM DU LANGUEDOC?

ChartMill assigns a fundamental rating of 2 / 10 to CRLA.PA.


What is the valuation status for CRLA stock?

ChartMill assigns a valuation rating of 2 / 10 to CRCAM DU LANGUEDOC (CRLA.PA). This can be considered as Overvalued.


Can you provide the profitability details for CRCAM DU LANGUEDOC?

CRCAM DU LANGUEDOC (CRLA.PA) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for CRLA stock?

The Price/Earnings (PE) ratio for CRCAM DU LANGUEDOC (CRLA.PA) is 8.65 and the Price/Book (PB) ratio is 0.03.


Is the dividend of CRCAM DU LANGUEDOC sustainable?

The dividend rating of CRCAM DU LANGUEDOC (CRLA.PA) is 3 / 10 and the dividend payout ratio is 0%.